SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Induction of labour at 39 weeks and adverse outcomes in low-risk pregnancies according to ethnicity, socioeconomic deprivation, and parity: A national cohort study in England.

Muller, P; Karia, AM; Webster, K; Carroll, F; Dunn, G; Frémeaux, A; Harris, T; Knight, H; Oddie, S; Khalil, A; et al. Muller, P; Karia, AM; Webster, K; Carroll, F; Dunn, G; Frémeaux, A; Harris, T; Knight, H; Oddie, S; Khalil, A; Van Der Meulen, J; Gurol-Urganci, I (2023) Induction of labour at 39 weeks and adverse outcomes in low-risk pregnancies according to ethnicity, socioeconomic deprivation, and parity: A national cohort study in England. PLoS Med, 20 (7). e1004259. ISSN 1549-1676 https://doi.org/10.1371/journal.pmed.1004259
SGUL Authors: Khalil, Asma

[img]
Preview
PDF Published Version
Available under License Creative Commons Attribution.

Download (1MB) | Preview
[img] Microsoft Word (.doc) (S1 STROBE Checklist) Published Version
Available under License Creative Commons Attribution.

Download (124kB)
[img] Microsoft Word (.docx) (S1 Table) Published Version
Available under License Creative Commons Attribution.

Download (20kB)
[img] Microsoft Word (.docx) (S2 Table) Published Version
Available under License Creative Commons Attribution.

Download (20kB)
[img] Microsoft Word (.docx) (S3 Table) Published Version
Available under License Creative Commons Attribution.

Download (24kB)
[img] Microsoft Word (.docx) (S4 Table) Published Version
Available under License Creative Commons Attribution.

Download (23kB)
[img] Microsoft Word (.docx) (S5 Table) Published Version
Available under License Creative Commons Attribution.

Download (22kB)

Abstract

BACKGROUND: Ethnic and socioeconomic inequalities in obstetric outcomes are well established. However, the role of induction of labour (IOL) to reduce these inequalities is controversial, in part due to insufficient evidence. This national cohort study aimed to identify adverse perinatal outcomes associated with IOL with birth at 39 weeks of gestation ("IOL group") compared to expectant management ("expectant management group") according to maternal characteristics in women with low-risk pregnancies. METHODS AND FINDINGS: All English National Health Service (NHS) hospital births between January 2018 and March 2021 were examined. Using the Hospital Episode Statistics (HES) dataset, maternal and neonatal data (demographic, diagnoses, procedures, labour, and birth details) were linked, with neonatal mortality data from the Office for National Statistics (ONS). Women with a low-risk pregnancy were identified by excluding pregnancies with preexisting comorbidities, previous cesarean section, breech presentation, placenta previa, gestational diabetes, or a baby with congenital abnormalities. Women with premature rupture of membranes, placental abruption, hypertensive disorders of pregnancy, amniotic fluid abnormalities, or antepartum stillbirth were excluded only from the IOL group. Adverse perinatal outcome was defined as stillbirth, neonatal death, or neonatal morbidity, the latter identified using the English composite neonatal outcome indicator (E-NAOI). Binomial regression models estimated risk differences (with 95% confidence intervals (CIs)) between the IOL group and the expectant management group, adjusting for ethnicity, socioeconomic background, maternal age, parity, year of birth, and birthweight centile. Interaction tests examined risk differences according to ethnicity, socioeconomic background, and parity. Of the 1 567 004 women with singleton pregnancies, 501 072 women with low-risk pregnancies and with sufficient data quality were included in the analysis. Approximately 3.3% of births in the IOL group (1 555/47 352) and 3.6% in the expectant management group (16 525/453 720) had an adverse perinatal outcome. After adjustment, a lower risk of adverse perinatal outcomes was found in the IOL group (risk difference -0.28%; 95% CI -0.43%, -0.12%; p = 0.001). This risk difference varied according to socioeconomic background from 0.38% (-0.08%, 0.83%) in the least deprived to -0.48% (-0.76%, -0.20%) in the most deprived national quintile (p-value for interaction = 0.01) and by parity with risk difference of -0.54% (-0.80%, -0.27%) in nulliparous women and -0.15% (-0.35%, 0.04%) in multiparous women (p-value for interaction = 0.02). There was no statistically significant evidence that risk differences varied according to ethnicity (p = 0.19). Key limitations included absence of additional confounding factors such as smoking, BMI, and the indication for induction in the HES datasets, which may mean some higher risk pregnancies were included. CONCLUSIONS: IOL with birth at 39 weeks was associated with a small reduction in the risk of adverse perinatal outcomes, with 360 inductions in low-risk pregnancies needed to avoid 1 adverse outcome. The risk reduction was mainly present in women from more socioeconomically deprived areas and in nulliparous women. There was no significant risk difference found by ethnicity. Increased uptake of IOL at 39 weeks, especially in women from more socioeconomically deprived areas, may help reduce inequalities in adverse perinatal outcomes.

Item Type: Article
Additional Information: Copyright: © 2023 Muller et al. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Keywords: Infant, Newborn, Pregnancy, Female, Humans, Parity, Stillbirth, Cesarean Section, Cohort Studies, Ethnicity, State Medicine, Placenta, Labor, Induced, England, Socioeconomic Factors, Placenta, Humans, Cesarean Section, Labor, Induced, Cohort Studies, Parity, Pregnancy, Socioeconomic Factors, Infant, Newborn, State Medicine, England, Female, Stillbirth, Ethnicity, 11 Medical and Health Sciences, General & Internal Medicine
SGUL Research Institute / Research Centre: Academic Structure > Molecular and Clinical Sciences Research Institute (MCS)
Journal or Publication Title: PLoS Med
ISSN: 1549-1676
Language: eng
Dates:
DateEvent
20 July 2023Published
12 June 2023Accepted
Publisher License: Creative Commons: Attribution 4.0
PubMed ID: 37471395
Go to PubMed abstract
URI: https://openaccess.sgul.ac.uk/id/eprint/115576
Publisher's version: https://doi.org/10.1371/journal.pmed.1004259

Actions (login required)

Edit Item Edit Item